Brief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
28/10/2026 20:27
BRIEF-Adial Pharmaceuticals Announces Name Change To Azora Therapeutics Oct 28 (Reuters) - Adial Pharmaceuticals Inc ADIL.O:
ADIAL PHARMACEUTICALS ANNOUNCES NAME CHANGE TO AZORA THERAPEUTICS AND NEW EXECUTIVE TEAM, FOCUSED ON ADVANCING AT177, AN ORAL, COLON-TARGETED AHR AGONIST FOR ULCERATIVE COLITIS
ADIAL PHARMACEUTICALS - CO'S COMMON STOCK TO TRADE AS 'AZR' ON NASDAQ ON OCT 29, 2026
ADIAL PHARMACEUTICALS - APPOINTS MATT DAVIDSON AS PRESIDENT AND CEO EFFECTIVE TODAY
ADIAL PHARMACEUTICALS - APPOINTS CELIA ECONOMIDES AS CHIEF FINANCIAL OFFICER
ADIAL PHARMACEUTICALS - AZORA EXPECTS TO INITIATE PHASE 1 TRIAL OF AT177 IN H1 2027
Source text: ID:nGNX311wc4
Further company coverage: ADIL.O